New laser treatment approaches for benign prostatic hyperplasia

Nathaniel M. Fried

Research output: Contribution to journalArticle

Abstract

The recent introduction of higher power 100 W holmium:yttrium-aluminum- garnet (Ho:YAG) and 80 W potassium titanyl phosphate lasers for rapid incision and vaporization of the prostate has resulted in renewed interest in the use of lasers for treatment of benign prostatic hyperplasia (BPH). Although long-term studies are still lacking, short-term results demonstrate that these procedures are at least as safe and effective in relieving BPH symptoms as transurethral resection of the prostate and may provide reduced morbidity. Other laser techniques, such as interstitial laser coagulation and contact laser vaporization of the prostate, have lost popularity due to complications with increased catheterization time, irritative symptoms, and infection rates. Although Ho:YAG laser enucleation of the prostate is more difficult to learn and a slower procedure than potassium titanyl phosphate laser vaporization, the Ho:YAG laser is currently the most proven laser technique for BPH treatment. This article reviews the latest developments in laser treatment of BPH over the past 2 years and provides a view toward the future of lasers in the treatment of BPH.

Original languageEnglish (US)
Pages (from-to)47-52
Number of pages6
JournalCurrent Urology Reports
Volume8
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Prostatic Hyperplasia
Holmium
Solid-State Lasers
Lasers
Prostate
Laser Therapy
Laser Coagulation
Therapeutics
Transurethral Resection of Prostate
Volatilization
Catheterization
Morbidity
Infection

ASJC Scopus subject areas

  • Urology

Cite this

New laser treatment approaches for benign prostatic hyperplasia. / Fried, Nathaniel M.

In: Current Urology Reports, Vol. 8, No. 1, 01.2007, p. 47-52.

Research output: Contribution to journalArticle

Fried, Nathaniel M. / New laser treatment approaches for benign prostatic hyperplasia. In: Current Urology Reports. 2007 ; Vol. 8, No. 1. pp. 47-52.
@article{1f6f3e180f9e4671ba4189fd8b6f733c,
title = "New laser treatment approaches for benign prostatic hyperplasia",
abstract = "The recent introduction of higher power 100 W holmium:yttrium-aluminum- garnet (Ho:YAG) and 80 W potassium titanyl phosphate lasers for rapid incision and vaporization of the prostate has resulted in renewed interest in the use of lasers for treatment of benign prostatic hyperplasia (BPH). Although long-term studies are still lacking, short-term results demonstrate that these procedures are at least as safe and effective in relieving BPH symptoms as transurethral resection of the prostate and may provide reduced morbidity. Other laser techniques, such as interstitial laser coagulation and contact laser vaporization of the prostate, have lost popularity due to complications with increased catheterization time, irritative symptoms, and infection rates. Although Ho:YAG laser enucleation of the prostate is more difficult to learn and a slower procedure than potassium titanyl phosphate laser vaporization, the Ho:YAG laser is currently the most proven laser technique for BPH treatment. This article reviews the latest developments in laser treatment of BPH over the past 2 years and provides a view toward the future of lasers in the treatment of BPH.",
author = "Fried, {Nathaniel M.}",
year = "2007",
month = "1",
doi = "10.1007/s11934-007-0020-x",
language = "English (US)",
volume = "8",
pages = "47--52",
journal = "Current Urology Reports",
issn = "1527-2737",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - New laser treatment approaches for benign prostatic hyperplasia

AU - Fried, Nathaniel M.

PY - 2007/1

Y1 - 2007/1

N2 - The recent introduction of higher power 100 W holmium:yttrium-aluminum- garnet (Ho:YAG) and 80 W potassium titanyl phosphate lasers for rapid incision and vaporization of the prostate has resulted in renewed interest in the use of lasers for treatment of benign prostatic hyperplasia (BPH). Although long-term studies are still lacking, short-term results demonstrate that these procedures are at least as safe and effective in relieving BPH symptoms as transurethral resection of the prostate and may provide reduced morbidity. Other laser techniques, such as interstitial laser coagulation and contact laser vaporization of the prostate, have lost popularity due to complications with increased catheterization time, irritative symptoms, and infection rates. Although Ho:YAG laser enucleation of the prostate is more difficult to learn and a slower procedure than potassium titanyl phosphate laser vaporization, the Ho:YAG laser is currently the most proven laser technique for BPH treatment. This article reviews the latest developments in laser treatment of BPH over the past 2 years and provides a view toward the future of lasers in the treatment of BPH.

AB - The recent introduction of higher power 100 W holmium:yttrium-aluminum- garnet (Ho:YAG) and 80 W potassium titanyl phosphate lasers for rapid incision and vaporization of the prostate has resulted in renewed interest in the use of lasers for treatment of benign prostatic hyperplasia (BPH). Although long-term studies are still lacking, short-term results demonstrate that these procedures are at least as safe and effective in relieving BPH symptoms as transurethral resection of the prostate and may provide reduced morbidity. Other laser techniques, such as interstitial laser coagulation and contact laser vaporization of the prostate, have lost popularity due to complications with increased catheterization time, irritative symptoms, and infection rates. Although Ho:YAG laser enucleation of the prostate is more difficult to learn and a slower procedure than potassium titanyl phosphate laser vaporization, the Ho:YAG laser is currently the most proven laser technique for BPH treatment. This article reviews the latest developments in laser treatment of BPH over the past 2 years and provides a view toward the future of lasers in the treatment of BPH.

UR - http://www.scopus.com/inward/record.url?scp=33846846641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846846641&partnerID=8YFLogxK

U2 - 10.1007/s11934-007-0020-x

DO - 10.1007/s11934-007-0020-x

M3 - Article

C2 - 17239316

AN - SCOPUS:33846846641

VL - 8

SP - 47

EP - 52

JO - Current Urology Reports

JF - Current Urology Reports

SN - 1527-2737

IS - 1

ER -